Archive for November, 2016

Analytical Challenges and Opportunities Associated with the Analysis and Interpretation of Clinical Studies in Precision Medicine

Posted on:

Recent advances in technology have led to a proliferation of data and in genomic testing alternatives for complex diseases as more treatment options are developed to target genomic and/or proteomic alterations in subsets of the overall population. Due to these recent advances in the capturing of genomic variables (Kalf et al., 2015; Marzuillo et al., 2014), there has been an increased clinical, analytical and regulatory need to identify genomic and proteomic biomarkers relevant to drug response. The challenge precision medicine studies face is that patients are sampled from a population that (due to practical constrains) are not usually fully representative of…

Read More »